Search for: "Mays et al v. General Motors LLC et al" Results 81 - 97 of 97
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Apr 2017, 3:01 pm
The syllabus is constructed with these general ideas in mind. [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey… [read post]
22 Dec 2008, 12:07 pm
General Motors Corp 6th Affirms Pro Se $120,000 Employment Discrimination VerdictMadden v. [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
25 Apr 2015, 11:03 am by Schachtman
See also Manual at 614 n. 198., citing Ofer Shpilberg, et al., The Next Stage: Molecular Epidemiology, 50 J. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
How obvious it is to the general public that the recalled product is deficient. [read post]
31 Jul 2018, 10:40 am by Kevin Kaufman
Generous public pensions, meanwhile, are beginning to catch up with the state, particularly as the population declines. [read post]